as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.99%
Downside
3.30%
Upside
52 Week's Low
52 Week's High
10.26%
Downside
57.89%
Upside
Check Bio-techne Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.0B
EPS (TTM)
1.9075
Dividend Yield
0.43%
Quarterly Earnings Growth YOY
-0.55%
PE Ratio (TTM)
111.43
Industry PE ratio
16.65525641025641
P/B Ratio
111.4348
PEG Ratio
0.71
EBITDA
331.1M
Revenue (TTM)
1.2B
Profit Margin
6.02%
Return On Equity TTM
3.68%
Track how Bio-techne Corp. P/E has moved over time to understand its valuation trends.
Bio-techne Corp. in the last 5 years
Lowest (26.04x)
June 30, 2025
Industry (16.66x)
September 13, 2025
Today (111.43x)
September 13, 2025
Highest (67.99x)
September 30, 2021
Today’s Price to Earnings Ratio: 111.43x
Compare market cap, revenue, PE, and other key metrics of Bio-techne Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $8.0B | -15.88% | 111.43 | 6.02% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Bio-techne Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bio-techne Corp. investment value today
Current value as on today
₹73,801
Returns
Returns from Bio-techne Corp. Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 19 analysts
84.21%
Buy
15.79%
Hold
0.00%
Sell
Based on 19 analysts, 84.21% of analysts recommend a 'BUY' rating for Bio-techne Corp.. Average target price of $66.23
Get share price movements and forecasts by analysts on Bio-techne Corp..
What analysts predicted
22.59%UPSIDE
Target Price
$66.23
Current Price
$51.27
Analyzed by
19 Analysts
Target
$66.23
Bio-techne Corp. target price $66.23, a slight upside of 22.59% compared to current price of $51.27. According to 19 analysts rating.
Search interest for Bio-techne Corp. Stock has increased by 77% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:77% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Check out the Mutual Funds with significant holdings in Bio-techne Corp..
Today's Timeline - 21 August
Thu, 03:33 PM
-Citi upgrades Bio-Techne to Buy from Neutral, raising price target to $70, citing undervaluation and growth potential.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 289.45M → 316.96M (in $), with an average increase of 3.0% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 159.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 107.0%
Profit Down
Netprofit is down for the last 3 quarters, 34.89M → -17.67M (in $), with an average decrease of 106.8% per quarter
Price Dip
In the last 7 days, TECH stock has moved down by -5.8%
Organisation | Bio-techne Corp. |
Headquarters | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 |
Industry | Health Technology |
CEO | Mr. James T. Hippel CPA |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Cheryl Bethune | Senior VP & Chief Human Resources Officer |
Mr. Shane Bohnen | Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer |
Dr. Matthew F. McManus M.D., MBA, Ph.D. | President of Diagnostics & Spatial Biology |
Mr. Gerry Andros | Vice President of Sales and Marketing |
Mr. Martin Wirtz | Senior Vice President of Strategy & Corporate Development |
Mr. Luca Cicchetti | Managing Director |
Mr. James T. Hippel CPA | Executive VP of Finance & CFO |
Mr. William A. Geist | President of Protein Sciences Segment |
Dr. Gary J. Latham Ph.D. | VP & CTO |
Mr. David Clair C.F.A. | VP of Investor Relations & Corporate Development |
Bio-techne Corp. share price today is $51.27 as on at the close of the market. Bio-techne Corp. share today touched a day high of $52.96 and a low of $50.76.
Bio-techne Corp. share touched a 52 week high of $80.95 on and a 52 week low of $46.01 on . Bio-techne Corp. stock price today i.e. is closed at $51.27,which is 36.66% down from its 52 week high and 11.43% up from its 52 week low.
Bio-techne Corp. market capitalisation is $0.01T as on .
Indian investors can start investing in Bio-techne Corp. (TECH) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bio-techne Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bio-techne Corp. share’s latest price of $51.27 as on September 13, 2025 at 1:29 am IST, you will get 0.1950 shares of Bio-techne Corp.. Learn more about
fractional shares .
Bio-techne Corp. stock has given -15.88% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?